Conference
Results from the pivotal phase (Ph) 2b HERIZON-BTC-01 study: Zanidatamab in previously-treated HER2-amplified biliary tract cancer (BTC)
Authors
Pant S; Fan J; Oh D-Y; Choi HJ; Kim JW; Chang H-M; Bao L; Sun H-C; Mercade TM; Xie F
Volume
41
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
June 1, 2023
Name of conference
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Conference place
IL, Chicago
Conference start date
June 2, 2023
Conference end date
June 6, 2023
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
16
ISSN
0732-183X